Study Design: Retrospective Descriptive Study. Setting: Physical Medicine and Rehabilitation (PMR) Department, Regional Institute of Medical Sciences (RIMS), Imphal, a tertiary care teaching hospital in North East India Study Duration: 1st November 2011 to 31st October 2012. Objective: To study the profile of traumatic spinal cord injury (SCI) patients admitted in PMR Department, RIMS. Materials and Methods: Neurological profile of traumatic SCI patients admitted in PMR Department, RIMS was recorded using a structured proforma and analysed. Demographic profile of the patients, time since injury, functional status and complications were also recorded. Results: Among all 22 patients, 16(72.7%) were tetraplegics with C5 (59.09%) as the most common neurological level involved. Twelve (54.5%) were American Spinal Injury Association (ASIA) grade A. The mean motor and sensory scores were 45±24.97 and 157.50±69.53 respectively. The mean FIM score (at admission) was 71.50±23.40 and FIM (at discharge) was 82.35±20.72. Spasticity was present in 16 cases (72.7%) with gastrosoleus as most common site. There were 14 patients (63.6%) who had urinary tract infection (UTI). Only 5(22.7%) underwent urodynamic study and all had hyperactive detrussor. The most common mode of bladder management was clean intermittent catheterisation (CIC) which was done in 16 patients (72.7%). Pressure sore was seen in 14(63.6%) of patients with sacrum (78.57%) as the most common site. Conclusion: Majority of traumatic SCI inpatients were of ASIA grade A and tetraplegics were commoner. Fall from height was the comonest cause of injury. Spasticity, UTI and pressure sores were common complications.
Original Article
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.